Macquarie US SmallCap A

Profile

This strategy mainly invests in (certificates of) shares of companies that are listed on the Canadian or US stock exchanges or where the majority of their activities take place in these countries. In addition, the strategy also preserves the possibility of investing in other instruments, including exchange traded funds (ETFs). The investment policy of the strategy is focused on selecting stocks and putting together a portfolio consisting of small and medium-sized listed companies. Macquarie US SmallCap focuses on realizing long-term value growth. The Fund is actively managed.

Management team

Delaware Investment Advisers

Performance per 2018-10-31

Slide to see more
  Fund
1 month -2.4 %
3 months 4.2 %
This year 15.5 %
2016 2.3 %
2017 -0.5 %
1 year (on annual basis) 16.6 %
Since inception (on annual basis) i 10.3 %
More information can be found on the documents page of this fund

Key figures

Slide to see more
Total fund size
EUR 24.02 M 2018-10-31
Share class size
EUR 24.02 M 2018-10-31
Number of shares
874,812 2018-10-31
Net Asset Value i
EUR 26.53 2018-12-07
Transaction price i
EUR 27.03 2018-11-26
Macquarie US SmallCap (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Delaware Investment Advisers. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.
Macquarie US SmallCap (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Delaware Investment Advisers. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.

Performance per 2018-10-31

Slide to see more
  Fund
1 month -2.4 %
3 months 4.2 %
This year 15.5 %
2016 2.3 %
2017 -0.5 %
1 year (on annual basis) 16.6 %
Since inception (on annual basis) i 10.3 %

Dividends

Slide to see more
Distributing
No
Macquarie US SmallCap (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Delaware Investment Advisers. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.

Top 8 holdings (2018-10-31)

1.4 %
NORTHWESTERN CORP
1.3 %
MGIC INVESTMENT CORP
1.3 %
WNS HOLDINGS LTD-ADR
1.2 %
SPIRE SHS
1.2 %
NEENAH INC
1.2 %
ESSENT GROUP LTD
1.1 %
EXLSERVICE HOLDINGS INC
1.1 %
TETRA TECH INC
Totaal
9.8 %
Macquarie US SmallCap (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Delaware Investment Advisers. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.

Ongoing charges

Slide to see more
Ongoing charges last financial year i
1.43 %
The Ongoing Charges Figure of the last financial year relates to 2017.

Other costs

Slide to see more
Upward swing factor i
0.35 %
Downward swing factor i
0.35 %
Macquarie US SmallCap (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Delaware Investment Advisers. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.

Share class details

Slide to see more
Share class
A i
Investor type
Institutional & Private
Distributing
No
Benchmark i
MSCI North American Index
Duration hedged
No
Investment category
Other
Universum
Small-& Mid-caps Worldwide
Inception date
2016-10-21
Domicile
The Netherlands
May be offered to all investors in
The Netherlands
UCITS status i
No
Status
Open-end i
Base currency
EUR
Share class currency
EUR
Administrator
BNP Paribas Securities Services S.C.A.
Auditor
Ernst & Young Accountants LLP
Transfer agent
F. van Lanschot Bankiers N.V.
Management company
Kempen Capital Management N.V.
Custodian
BNP Paribas Securities Services S.C.A.

Tradability

Slide to see more
Listed
no
Subscription/Redemption Frequency
Daily
ISIN i
NL0011983341
Macquarie US SmallCap will only be available for orders submitted via the Transfer Agent platform of F. van Lanschot Bankiers N.V. Participations will only be available for distributors who submit orders on behalf of their clients, and who have been selected by the management company.
Macquarie US SmallCap (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Delaware Investment Advisers. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.

Read more information about Kempen Capital Management N.V. on this site and find also more information on BNP Paribas Securities Services S.C.A.

Macquarie US SmallCap (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Delaware Investment Advisers. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.

KCM Vision

Kempen Capital Management is an asset manager with a long-term investment approach. We strongly believe in engaged shareholdership that benefits all stakeholders. As a long-term responsible investor, we firmly believe that active ownership and shareholder engagement contribute to positive change across the board.

Our KCM wide approach to responsible investment

To put our vision into action we engage with our investment targets on a wide array of strategic, financial, environmental, social and governance (ESG) topics. Our long-term investment worldview paired with thorough analysis and an experienced and diverse ESG team allow us to use both voting and engagement as means to consistently encourage positive change. Through this process of constructive engagement, we are able to contribute to the development of principles and standards of corporate responsibility within companies that we invest in. Our full voting records are available here.

Macquarie US SmallCap (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Delaware Investment Advisers. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.